HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideyuki Saya Selected Research

Oxyfedrine

1/2020Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideyuki Saya Research Topics

Disease

142Neoplasms (Cancer)
07/2022 - 02/2002
23Glioma (Gliomas)
01/2022 - 05/2003
21Neoplasm Metastasis (Metastasis)
03/2022 - 02/2007
18Glioblastoma (Glioblastoma Multiforme)
01/2022 - 10/2003
16Carcinogenesis
10/2021 - 12/2003
13Breast Neoplasms (Breast Cancer)
10/2021 - 07/2008
11Osteosarcoma (Osteogenic Sarcoma)
12/2021 - 08/2007
8Stomach Neoplasms (Stomach Cancer)
03/2022 - 06/2008
8Brain Neoplasms (Brain Tumor)
01/2019 - 10/2009
7Cholangiocarcinoma
03/2021 - 03/2010
6Inflammation (Inflammations)
10/2021 - 09/2013
6Melanoma (Melanoma, Malignant)
06/2021 - 11/2013
6Squamous Cell Carcinoma of Head and Neck
11/2019 - 02/2007
6Neurofibromatosis 1 (Neurofibromatosis Type I)
08/2010 - 03/2003
5Warts (Wart)
05/2012 - 10/2002
4Hypoxia (Hypoxemia)
03/2022 - 11/2002
4Astrocytoma (Pilocytic Astrocytoma)
10/2019 - 10/2003
4Leukemia
01/2019 - 10/2009
4Carcinoma (Carcinomatosis)
01/2019 - 01/2012
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 11/2013
3COVID-19
01/2022 - 01/2021
3Adenocarcinoma
05/2021 - 09/2016
3Pneumonia (Pneumonitis)
01/2021 - 01/2013
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021 - 03/2011
3Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 01/2016
3Fibrosis (Cirrhosis)
05/2018 - 02/2010
3Metaplasia
02/2017 - 10/2013
3Prostatic Neoplasms (Prostate Cancer)
05/2016 - 08/2007
3Retinoblastoma (Glioblastoma, Retinal)
06/2012 - 11/2006
2Disease Progression
01/2022 - 01/2016
2Circulating Neoplastic Cells
12/2021 - 01/2018
2Lymphoma (Lymphomas)
10/2020 - 11/2015

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2003
16Pharmaceutical PreparationsIBA
03/2021 - 03/2012
15Phosphotransferases (Kinase)IBA
10/2021 - 12/2003
14Sulfasalazine (Azulfidine)FDA LinkGeneric
03/2021 - 10/2013
13Protein Isoforms (Isoforms)IBA
07/2022 - 01/2012
12Biological ProductsIBA
01/2022 - 04/2010
12Glutathione (Reduced Glutathione)IBA
01/2020 - 01/2012
12Cystine (L-Cystine)IBA
11/2019 - 06/2012
10DNA (Deoxyribonucleic Acid)IBA
05/2022 - 05/2002
10Cisplatin (Platino)FDA LinkGeneric
03/2021 - 01/2016
10Glutamic Acid (Glutamate)FDA Link
11/2019 - 04/2015
9EnzymesIBA
03/2022 - 01/2005
9Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017 - 03/2011
8AntioxidantsIBA
01/2021 - 03/2012
8Small Interfering RNA (siRNA)IBA
12/2018 - 07/2008
8ErbB Receptors (EGF Receptor)IBA
12/2018 - 10/2003
7Biomarkers (Surrogate Marker)IBA
12/2021 - 05/2016
7Transcription Factors (Transcription Factor)IBA
01/2021 - 08/2010
7Cadherins (E-Cadherin)IBA
01/2021 - 07/2008
7Messenger RNA (mRNA)IBA
01/2020 - 03/2010
6LigandsIBA
10/2021 - 01/2014
6Neurofibromin 1 (Neurofibromin)IBA
01/2018 - 07/2003
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 03/2012
5Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 02/2002
5Hyaluronic Acid (Hyaluronan)IBA
01/2017 - 08/2003
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2015 - 06/2008
5Cyclin-Dependent Kinase Inhibitor p16IBA
06/2012 - 11/2006
4CytokinesIBA
10/2021 - 05/2009
4Celecoxib (Celebrex)FDA Link
01/2021 - 01/2017
4Epithelial Cell Adhesion MoleculeIBA
12/2020 - 11/2011
4AntiportersIBA
11/2019 - 09/2018
4Trastuzumab (Herceptin)FDA Link
01/2018 - 05/2008
4Monoclonal AntibodiesIBA
01/2016 - 08/2003
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2022 - 12/2017
3Oxygen (Dioxygen)IBA
01/2022 - 01/2018
3PeriostinIBA
06/2021 - 01/2015
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2021 - 01/2017
3LipidsIBA
01/2021 - 10/2012
3AntibodiesIBA
01/2021 - 01/2016
3Antineoplastic Agents (Antineoplastics)IBA
12/2020 - 08/2004
3Amino AcidsFDA Link
11/2019 - 10/2012
3MicellesIBA
10/2019 - 01/2016
3Histones (Histone)IBA
01/2019 - 05/2013
3Epidermal Growth Factor (EGF)IBA
12/2018 - 01/2014
3human ERBB2 proteinIBA
07/2018 - 06/2012
3Indicators and Reagents (Reagents)IBA
01/2018 - 05/2016
3spasmolytic polypeptideIBA
02/2017 - 10/2013
3Dinoprostone (PGE2)FDA Link
03/2016 - 03/2010
3Progesterone Receptors (Progesterone Receptor)IBA
12/2015 - 06/2012
3Estrogen ReceptorsIBA
12/2015 - 06/2012
3Pyruvate KinaseIBA
08/2014 - 03/2012
3GTPase-Activating Proteins (GTPase-Activating Protein)IBA
11/2005 - 07/2003
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
08/2005 - 10/2002
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2022 - 03/2012
2Mitogen-Activated Protein KinasesIBA
03/2022 - 09/2011
2trametinibIBA
03/2022 - 12/2021
2Peptide Hydrolases (Proteases)FDA Link
01/2022 - 08/2005
2Neutralizing AntibodiesIBA
01/2022 - 01/2021
2Fibronectins (Fibronectin)IBA
01/2022 - 06/2004
2Glycoproteins (Glycoprotein)IBA
06/2021 - 03/2014
2Lactic Acid (Lactate)FDA LinkGeneric
05/2021 - 01/2018
2Caspase 3 (Caspase-3)IBA
12/2020 - 11/2017

Therapy/Procedure

37Therapeutics
01/2021 - 05/2003
18Drug Therapy (Chemotherapy)
03/2021 - 07/2009
6Transplantation
03/2022 - 02/2010
4Radiotherapy
01/2020 - 01/2016
4Aftercare (After-Treatment)
01/2016 - 04/2005
2Lab-On-A-Chip Devices
01/2022 - 01/2017